Related Articles
Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and ‘frequent exacerbator’ phenotype
Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles
Respiratory diseases in the era of Covid‑19: Pearls and pitfalls
Blood CDC42 overexpression is associated with an increased risk of acute exacerbation, inflammation and disease severity in patients with chronic obstructive pulmonary disease
Assessment of anti‑reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux